Topical Therapy for Androgenetic Alopecia Clinical Trial
A Clinical trial by Pelage Pharmaceuticals announces positive results for a topical therapy for androgenetic alopecia. It is designed to reactivate dormant hair follicle stem cells
This is an important article addressing post-finasteride syndrome. More data is needed to clarify how common and who it is most likely to affect.